Dade's Emit II plus test for Ecstasy:
This article was originally published in Clinica
Executive Summary
Dade Behring has received US FDA 510K clearance to sell a rapid screening test for detecting Ecstasy in urine. The Emit II plus Ecstasy assay screens urine for the following illegal substances: methylenedioxymethamphetamine (MDMA, or "Ecstasy"), methylenedioxyethylamphetamine (MDEA) and methylenedioxyamphetamine (MDA). It complies with proposed SAMSHA (Substance Abuse and Mental Health Services Administration) and European regulations, and has approved applications for use on Dade's Syva 30R analyser and on systems made by Olympus. Its availability on Dade's Viva-E and V-Twin drug-testing systems is expected this month, with other open chemistry systems to follow, said the Deerfield, Illinois firm.